PL2643460T3 - Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV) - Google Patents
Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV)Info
- Publication number
- PL2643460T3 PL2643460T3 PL12801310T PL12801310T PL2643460T3 PL 2643460 T3 PL2643460 T3 PL 2643460T3 PL 12801310 T PL12801310 T PL 12801310T PL 12801310 T PL12801310 T PL 12801310T PL 2643460 T3 PL2643460 T3 PL 2643460T3
- Authority
- PL
- Poland
- Prior art keywords
- hiv
- kits
- compositions
- methods
- immunodeficiency virus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161497234P | 2011-06-15 | 2011-06-15 | |
| PCT/US2012/042365 WO2012174187A2 (en) | 2011-06-15 | 2012-06-14 | Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
| EP12801310.9A EP2643460B1 (en) | 2011-06-15 | 2012-06-14 | Methods, compositions, and kits for determining human immunodeficiency virus (hiv) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2643460T3 true PL2643460T3 (pl) | 2018-01-31 |
Family
ID=47357719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12801310T PL2643460T3 (pl) | 2011-06-15 | 2012-06-14 | Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV) |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9273366B2 (pl) |
| EP (1) | EP2643460B1 (pl) |
| CN (1) | CN103635575B (pl) |
| AR (1) | AR086925A1 (pl) |
| AU (1) | AU2012271672B2 (pl) |
| BR (1) | BR112013032223A2 (pl) |
| ES (1) | ES2644839T3 (pl) |
| HU (1) | HUE036963T2 (pl) |
| MX (1) | MX340053B (pl) |
| PL (1) | PL2643460T3 (pl) |
| PT (1) | PT2643460T (pl) |
| RU (1) | RU2584573C2 (pl) |
| UY (1) | UY34128A (pl) |
| WO (1) | WO2012174187A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10113206B2 (en) * | 2010-02-24 | 2018-10-30 | Grifols Therapeutics Inc. | Methods, compositions, and kits for determining human immunodeficiency virus (HIV) |
| CA2955771C (en) * | 2014-07-24 | 2022-08-30 | Abbott Molecular Inc. | Compositions and methods for the detection and analysis of mycobacterium tuberculosis |
| HK1255315A1 (zh) | 2015-07-14 | 2019-08-16 | Abbott Molecular Inc. | 用於鉴定耐药性结核的组合物和方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4605735A (en) | 1983-02-14 | 1986-08-12 | Wakunaga Seiyaku Kabushiki Kaisha | Oligonucleotide derivatives |
| US4757141A (en) | 1985-08-26 | 1988-07-12 | Applied Biosystems, Incorporated | Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof |
| US4826967A (en) | 1987-06-16 | 1989-05-02 | Naxcor | Psoralen-nucleoside adducts and method for their preparation |
| US5082934A (en) | 1989-04-05 | 1992-01-21 | Naxcor | Coumarin derivatives for use as nucleotide crosslinking reagents |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5847096A (en) * | 1991-08-30 | 1998-12-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | DNA constructs encoding CD4 fusion proteins |
| US6965020B2 (en) | 1996-01-23 | 2005-11-15 | Affymetrix, Inc. | Nucleic acid labeling compounds |
| CA2222769C (en) * | 1997-01-17 | 2001-06-12 | F. Hoffmann-La Roche Ag | Primers for the detection of hiv-1 |
| US6534273B2 (en) | 1997-05-02 | 2003-03-18 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
| EP1102786A4 (en) * | 1998-08-03 | 2002-03-06 | Univ East Carolina | AGENT COMPRISING ANTISENSE OLIGONUCLEOTIDES WITH LOW ADENOSINE CONTENT, COMPOSITION, KIT AND TREATMENTS |
| WO2000047599A1 (en) | 1999-02-12 | 2000-08-17 | Sankyo Company, Limited | Novel nucleosides and oligonucleotide analogues |
| US20040121335A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections |
| US20030027135A1 (en) * | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US20060073501A1 (en) * | 2004-09-10 | 2006-04-06 | Van Den Boom Dirk J | Methods for long-range sequence analysis of nucleic acids |
| WO2007073149A1 (en) | 2005-12-22 | 2007-06-28 | Keygene N.V. | Alternative nucleotides for improved targeted nucleotide exchange |
| KR20080037128A (ko) | 2006-10-25 | 2008-04-30 | 주식회사 씨젠 | 뉴클레오타이드 변이 검출 방법 |
| RU2011129765A (ru) | 2008-12-19 | 2013-01-27 | Эбботт Лэборетриз | Молекулярный тест, используемый для диагностики вич тропизма |
-
2012
- 2012-06-14 AR ARP120102105A patent/AR086925A1/es unknown
- 2012-06-14 AU AU2012271672A patent/AU2012271672B2/en not_active Ceased
- 2012-06-14 UY UY0001034128A patent/UY34128A/es not_active Application Discontinuation
- 2012-06-14 WO PCT/US2012/042365 patent/WO2012174187A2/en not_active Ceased
- 2012-06-14 MX MX2013013293A patent/MX340053B/es active IP Right Grant
- 2012-06-14 PT PT128013109T patent/PT2643460T/pt unknown
- 2012-06-14 US US14/119,563 patent/US9273366B2/en active Active
- 2012-06-14 CN CN201280028651.0A patent/CN103635575B/zh not_active Expired - Fee Related
- 2012-06-14 HU HUE12801310A patent/HUE036963T2/hu unknown
- 2012-06-14 BR BR112013032223A patent/BR112013032223A2/pt not_active Application Discontinuation
- 2012-06-14 RU RU2013151821/10A patent/RU2584573C2/ru active
- 2012-06-14 PL PL12801310T patent/PL2643460T3/pl unknown
- 2012-06-14 EP EP12801310.9A patent/EP2643460B1/en active Active
- 2012-06-14 ES ES12801310.9T patent/ES2644839T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2643460B1 (en) | 2017-07-26 |
| RU2584573C2 (ru) | 2016-05-20 |
| BR112013032223A2 (pt) | 2016-12-20 |
| AR086925A1 (es) | 2014-01-29 |
| ES2644839T3 (es) | 2017-11-30 |
| CN103635575B (zh) | 2019-03-01 |
| UY34128A (es) | 2013-01-31 |
| EP2643460A4 (en) | 2014-05-21 |
| WO2012174187A3 (en) | 2013-03-28 |
| AU2012271672B2 (en) | 2016-02-18 |
| AU2012271672A1 (en) | 2013-05-02 |
| US20140120526A1 (en) | 2014-05-01 |
| WO2012174187A2 (en) | 2012-12-20 |
| PT2643460T (pt) | 2017-10-24 |
| US9273366B2 (en) | 2016-03-01 |
| HUE036963T2 (hu) | 2018-08-28 |
| MX2013013293A (es) | 2013-12-12 |
| EP2643460A2 (en) | 2013-10-02 |
| RU2013151821A (ru) | 2015-05-27 |
| MX340053B (es) | 2016-06-22 |
| CN103635575A (zh) | 2014-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016202543A1 (en) | Human immunodeficiency virus (hiv)-neutralizing antibodies | |
| EP2707025B8 (en) | Hendra and nipah virus g glycoprotein immunogenic compositions | |
| PL3556396T3 (pl) | Przeciwciała neutralizujące ludzki wirus niedoboru odporności (hiv) | |
| HUE053545T2 (hu) | Humán immundeficiencia vírus semlegesítõ antitestek és eljárások alkalmazásukra | |
| EP2764102A4 (en) | METHOD AND COMPOSITIONS FOR REGULATING HIV INFECTIONS | |
| LT2408476T (lt) | Žmogaus imunodeficito virusą (živ) neutralizuojantys antikūnai | |
| EP2670419A1 (en) | Psa capture agents, compositions, methods and preparation thereof | |
| EP3052132A4 (en) | Antibody therapies for human immunodeficiency virus (hiv) | |
| ZA201307529B (en) | Truncated hiv envelope proteins (env), methods and compositions related thereto | |
| IL231132A0 (en) | Viral cleaning methods | |
| SG11201407089SA (en) | Cyclosporine-containing, non-irritative nanoemulsion opthalmic composition | |
| EP2763998A4 (en) | TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF | |
| IL228006B (en) | Endodontic instruments, kits and methods for using endodontic instruments | |
| EP2852662A4 (en) | HERPESVIRUS COMPOSITIONS AND RELATED METHODS | |
| BR112014003556A2 (pt) | método de tratamento de vírus, e, composição farmacêutica | |
| WO2013052095A3 (en) | Vaccine | |
| PT2710019T (pt) | Processos e intermediários para preparar agentes anti-hiv | |
| PL2643460T3 (pl) | Sposoby, kompozycje i zestawy do oznaczania ludzkiego wirusa niedoboru odporności (HIV) | |
| IL231494A0 (en) | Lentiviral genome without chimeric integration as components against hiv-1 | |
| WO2012139097A3 (en) | Method of inducing neutralizing antibodies to human immunodeficiency virus | |
| ZA201307019B (en) | Compositions for preventing and/or treating and infection by an hiv-1 virus | |
| PT2643461T (pt) | Métodos, composições e kits para determinação do vírus da hepatite a | |
| IL227688A0 (en) | History of aminostatin, their preparation and pharmaceutical preparations containing them | |
| BR112014014825A8 (pt) | composições naturais, de liberação múltipla e de reutilização | |
| SG11201402899TA (en) | Methods and compositions for treating viral diseases |